This pioneering randomized controlled trial by Fitzpatrick et al. (2017) provided the first clinical evidence that a fully automated AI chatbot could effectively deliver cognitive behavioral therapy (CBT).
Woebot, an AI conversational agent, was tested with 70 young adults (18-28 years) experiencing symptoms of depression and anxiety. Over two weeks of daily check-ins:
- The Woebot group showed a significant reduction in depression symptoms (PHQ-9) compared to the control group
- Anxiety symptoms also decreased significantly
- Engagement was remarkably high: participants used Woebot an average of 12.14 out of 14 days
Sweet Implications
The study demonstrated that AI-delivered therapy could be a scalable solution for the global mental health treatment gap — an estimated 75% of people in developing countries receive no treatment for mental health conditions.
Bitter Caveats
The study had limitations: short duration (2 weeks), small sample, no long-term follow-up, and the comparison was with an information-only ebook, not human therapy. Subsequent research has raised concerns about over-reliance on AI therapy and the risk of replacing, rather than supplementing, human clinicians.
Source
Fitzpatrick, K. K., Darcy, A., & Vierhile, M. (2017). Delivering CBT to Young Adults via Woebot. JMIR Mental Health, 4(2), e19.